ArticleVeterinary medicine and science2026
Successful Treatment of Mycobacterium caprae Infection in Two UK Cats.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 4-year-old, male-neutered Savannah cat (Case 1) and a 3-year-old female-neutered British shorthair cat (Case 2) were each investigated for chronic coughing, lethargy and weight loss. Thoracic imaging revealed diffuse broncho-interstitial changes and multifocal soft-tissue nodules (Case 1), and two cavitating masses in the left lung (Case 2). Bronchoalveolar lavage cytology (BAL) in both cases identified macrophagic inflammation with acid-fast bacilli and was culture (Case 1) or PCR (Case 2) positive for Mycobacterium caprae. The cats were treated with 11 months (Case 1) and 9 months (Case 2) of triple antimicrobial therapy comprising pradofloxacin (5 mg/kg orally once every 24 h), rifampicin (10 mg/kg orally once every 24 h) and azithromycin (15 mg/kg orally once every 24 h). Both made complete clinical recoveries and radiographic improvement in the thoracic changes were static for 2 months prior to cessation of therapy. Both cats remain clinically well 12 and 10 months after cessation of treatment, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.